Medical management of pediatric stone disease.
Childhood urolithiasis remains endemic in certain parts of the world, namely, Turkey and the Far East. The prevalence of nephrolithiasis in North American children varies widely among geographic regions and accounts for 1 per 1000 to 1 per 7600 pediatric hospital admissions. Stones occur in children of all ages. The clinical manifestations of stone disease are often more subtle in children when compared with the dramatic adult presentation. This article discusses the evaluation and medical management of pediatric stone disease.
Bartosh
Sharon M
SM
Department of Pediatrics, University of Wisconsin, University of Wisconsin Children's Hospital, 600 Highland Avenue, Madison, WI 53792, USA.
D002118:Calcium / Q000652:urine; D002648:Child; D003555:Cystinuria / Q000150:complications; D006801:Humans; D006960:Hyperoxaluria, Primary / Q000150:complications; D017616:Magnesium Compounds; D010710:Phosphates; D000069877:Struvite; D014527:Uric Acid / Q000378:metabolism; D001744:Urinary Bladder Calculi / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D014545:Urinary Calculi / Q000737:chemistry / Q000150:complications / Q000175:diagnosis* / Q000628:therapy
D017616:Magnesium Compounds; D010710:Phosphates; D014527:Uric Acid; D000069877:Struvite; D002118:Calcium